Skip to NavigationSkip to content

News

Smaller local hospitals are to become important centres for developing patient-centred care in a reversal of what the Government calls the iggest is...
The 'risk sharing' scheme to provide multiple sclerosis treatments is a waste of money and scientifically unsound, according to new report.
Fourteen PCTs have been given the go-ahead to develop new and innovative services and improve patient services through community pharmacists.
AstraZeneca has submitted new data on its uperstatincholesterol-lowering drug Crestor to convince the US authorities of its safety profile.
GlaxoSmithKline Chief Executive Jean-Pierre Garnier says he believes the company has urned a cornerin halting the decline in its R&D productivity...
Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.
Serono is to withdraw one of its hormone products from the UK after a case of variant Creutzfeldt-Jakob disease was confirmed in Italy, where the...
AstraZeneca has submitted its lung cancer drug Iressa for approval in Europe, despite concerns about side-effects.
Pressure from shareholders has prompted UK vaccines group PowderJect to split the roles of chairman and chief executive.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches